Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - Immunoclin Corpexhibit322.htm
EX-10.7 - EXHIBIT 10.7 - Immunoclin Corpexhibit107.htm
10-K - FORM 10-K - Immunoclin Corpform10k.htm
EX-31.2 - EXHIBIT 31.2 - Immunoclin Corpexhibit312.htm
EX-31.1 - EXHIBIT 31.1 - Immunoclin Corpexhibit311.htm
EXCEL - IDEA: XBRL DOCUMENT - Immunoclin CorpFinancial_Report.xls

 

Exhibit 32.1


Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002


In connection with the Annual Report of Immunoclin Corporation, (the Company) on Form 10-K for the year ended January 31, 2014, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Dorothy Bray, Chief Executive Officer of the Company certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


1.   

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

 


 

By: /s/ Dorothy Bray

Dorothy Bray

President and Chief Executive Officer


July 2, 2014